Predictors of disease burden in patients with untreated transthyretin amyloid cardiomyopathy and their caregivers: a post hoc analysis of an international survey.

Saved in:
Bibliographic Details
Title: Predictors of disease burden in patients with untreated transthyretin amyloid cardiomyopathy and their caregivers: a post hoc analysis of an international survey.
Authors: Cappelli F; Tuscan Regional Amyloidosis Referral Centre, Careggi University Hospital, Florence, Italy., Ponti L; University of Urbino, Urbino, Italy., Hsu K; Amyloidosis Research Consortium, Newton, MA, United States., Damy T; Henri Mondor Hospital, Paris, France., Villacorta E; Complejo Asistencial Universitario de Salamanca, Salamanca, Spain., Verheyen N; Medical University of Graz, Graz, Austria., Keohane D; Pfizer Inc., New York, NY, United States., Wang R; Pfizer Inc., Groton, CT, United States., Ines M; Pfizer Inc., Porto Salvo, Portugal., Kumar N; Pfizer Inc., New York, NY, United States., Munteanu C; Pfizer Inc., New York, NY, United States.
Source: Frontiers in cardiovascular medicine [Front Cardiovasc Med] 2025 Jun 09; Vol. 12, pp. 1595797. Date of Electronic Publication: 2025 Jun 09 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101653388 Publication Model: eCollection Cited Medium: Print ISSN: 2297-055X (Print) Linking ISSN: 2297055X NLM ISO Abbreviation: Front Cardiovasc Med Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2297-055X
DOI:10.3389/fcvm.2025.1595797